Ashley Gallagher

Ashley Gallagher is an associate editor for Pharmacy Times.


Dr Lakesha Farmer Highlights Current Biosimilar Education, Acceptance Efforts

June 09, 2024

Cencora's Lakesha Farmer, PharmD, MBA, discusses efforts that health care organizations can take to better educate patients and providers on biosimilars to improve biosimilar acceptance and achieve cost savings associated with these products.

Insights From Cencora's Dr Lakesha Farmer: Innovative Biosimilar Adoption Strategies

May 26, 2024

Lakesha Farmer, PharmD, MBA, from Cencora discusses innovative pricing and reimbursement models incentivizing biosimilar adoption and competitiveness, including dual pricing strategies and the Mark Cuban Cost Plus Program, while highlighting potential impacts on patient assistance programs.

Why Are Companies Launching Biosimilars With 2 Prices? Julie Reed Explains

July 30, 2023

Why are companies pricing their adalimumab biosimilars with 2 prices? Can the United States expect more of this pricing strategy for future biosimilar launches? Julie Reed, executive director of the Biosimilars Forum, has the answers.

Julie Reed: When the US Could See Meaningful Savings From Adalimumab, Ranibizumab Biosimilar Competition

June 25, 2023

Juliana (Julie) Reed, executive director of the Biosimilars Forum, predicts how long it will take for savings from adalimumab and ranibizumab biosimilar competition to fully manifest and how stakeholders can champion for better market competition for biosimilars.